SYRINGE-MEDIATED DRUG-SHARING (BACKLOADING) - A NEW RISK FACTOR FOR HIV AMONG INJECTING DRUG-USERS

被引:106
作者
JOSE, B
FRIEDMAN, SR
NEAIGUS, A
CURTIS, R
GRUND, JPC
GOLDSTEIN, MF
WARD, TP
JARLAIS, DCD
机构
[1] TRAINING & DEV,DV8 RES,ROTTERDAM,NETHERLANDS
[2] BETH ISRAEL MED CTR,NEW YORK,NY 10003
关键词
HIV; AIDS; INJECTING DRUG USERS; DRUG-SHARING; BACKLOADING; HIV SEROPOSITIVITY; RISK FACTOR;
D O I
10.1097/00002030-199312000-00017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: In syringe-mediated drug-sharing (backloading), injecting drug users (IDU) use their syringes to mix drugs and to give measured shares to other IDU by squirting drug solution into the syringes of other IDU. Backloading has been discussed as a potential HIV risk factor, but its role as an HIV transmission route has not been established empirically. Methods: Six hundred and sixty IDU who had injected drugs in the previous 2 years were street-recruited from Bushwick, New York City through chain referral, tested for HIV antibody and interviewed about sexual and drug-risk behaviors. Results: Receiving drugs via backloading in the previous 2 years was reported by 24.5% of the subjects. These subjects had significantly higher HIV seroprevalence than those who did not receive drugs by backloading (odds ratio, 2.2; 95% confidence interval, 1.5-3.1). Backloading remained positively and significantly associated with HIV seropositivity in stepwise logistic regression, and in a series of simultaneous logistic models controlling for sociodemographic variables and for sexual and drug risk variables. Conclusions: Backloading can be a route of HIV transmission among IDU and should be incorporated into risk-factor studies and HIV transmission modeling. Many IDU who avoid other high-risk drug-injection practices may overlook the risk of backloading. HIV prevention programs should warn IDU against syringe-mediated drug-sharing and work together to develop ways to avoid it.
引用
收藏
页码:1653 / 1660
页数:8
相关论文
共 23 条
[1]  
BORNEMANN R, 1990, 1ST INT C RED DRUG R
[2]   PSYCHOLOGICAL AND BEHAVIORAL IMPACT AMONG INTRAVENOUS-DRUG-USERS OF LEARNING HIV TEST-RESULTS [J].
CASADONTE, PP ;
DESJARLAIS, DC ;
FRIEDMAN, SR ;
ROTROSEN, JP .
INTERNATIONAL JOURNAL OF THE ADDICTIONS, 1990, 25 (04) :409-426
[3]   HUMAN IMMUNODEFICIENCY VIRUS-INFECTION IN HETEROSEXUAL INTRAVENOUS-DRUG-USERS IN SAN-FRANCISCO [J].
CHAISSON, RE ;
MOSS, AR ;
ONISHI, R ;
OSMOND, D ;
CARLSON, JR .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1987, 77 (02) :169-172
[4]  
CLARK G, 1993, 9 INT C AIDS 4 STD W
[5]   INTERNATIONAL EPIDEMIOLOGY OF HIV AND AIDS AMONG INJECTING DRUG-USERS [J].
DESJARLAIS, DC ;
FRIEDMAN, SR ;
CHOOPANYA, K ;
VANICHSENI, S ;
WARD, TP .
AIDS, 1992, 6 (10) :1053-1068
[6]  
DESJARLAIS DC, 1988, REV INFECT DIS, V10, P151
[7]   HISTORY, BIOGRAPHY, AND HIV-INFECTION [J].
FRIEDMAN, SR ;
KLEINMAN, PH ;
JARLAIS, DCD .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1992, 82 (01) :125-125
[8]  
GOLDSTEIN M, 1993, 121ST ANN M AM PUBL
[9]  
GRUND JPC, 1991, J PSYCHOACTIVE DRUGS, V23, P1
[10]  
GRUND JPC, 1990, AIDS, V4, P819, DOI 10.1097/00002030-199008000-00020